Patent details

EP4025253 Title: DRUG ANTIBODY CONJUGATES

Basic Information

Publication number:
EP4025253
PCT Application Number:
EP2020074695
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP207644063
PCT Publication Number:
WO2021043951
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DRUG ANTIBODY CONJUGATES
French Title of Invention:
CONJUGUÉS ANTICORPS-MÉDICAMENTS
German Title of Invention:
ARZNEIMITTEL-ANTIKÖRPER-KONJUGATE
SPC Number:

Dates

Filing date:
04/09/2020
Grant date:
20/03/2024
EP Publication Date:
13/07/2022
PCT Publication Date:
11/03/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/03/2024
EP B1 Publication Date:
20/03/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/09/2024
Expiration date:
04/09/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/03/2024
 
 

Name:
Pharma Mar, S.A.
Address:
Polígono Industrial La Mina Avda. de los Reyes, 1 Colmenar Viejo, 28770 Madrid, Spain (ES)

Inventor

1

Name:
GUTIÉRREZ LORIENTE, Agustín
Address:
Spain (ES)

2

Name:
LATORRE LOZANO, Alfonso
Address:
Spain (ES)

3

Name:
CUEVAS MARCHANTE, Maria Del Carmen
Address:
Spain (ES)

Priority

Priority Number:
19382765
Priority Date:
05/09/2019
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 47/68; A61K 31/351; C07D 309/10;

Publication

European Patent Bulletin

Issue number:
202412
Publication date:
20/03/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages